Anthony T. Vella
Affiliations: | Oregon State University, Corvallis, OR |
Area:
Immunology, Cell BiologyGoogle:
"Anthony Vella"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sutter PA, Ménoret A, Jellison ER, et al. (2023) CD8+ T cell depletion prevents neuropathology in a mouse model of globoid cell leukodystrophy. The Journal of Experimental Medicine. 220 |
| Ménoret A, Agliano F, Karginov TA, et al. (2023) Antigen-specific downregulation of miR-150 in CD4 T cells promotes cell survival. Frontiers in Immunology. 14: 1102403 |
| Karginov TA, Ménoret A, Vella AT. (2022) Optimal CD8 T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape. Nature Communications. 13: 3540 |
| Agliano F, Ménoret A, Vella AT. (2022) Evaluating the glycolytic potential of mouse costimulated effector CD8 T cells . Star Protocols. 3: 101441 |
| Agliano F, Karginov TA, Ménoret A, et al. (2022) Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling. Iscience. 25: 103932 |
| Li C, Phoon YP, Karlinsey K, et al. (2022) A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients. The Journal of Experimental Medicine. 219 |
| Agliano F, Karlinsey KS, Ragazzi M, et al. (2020) A benzimidazole inhibitor attenuates sterile inflammation induced in a model of systemic autoinflammation in female mice Scientific Reports. 10: 12100 |
| Li C, Phoon YP, Karlinsey K, et al. (2020) P853 Single cell transcriptome analysis identifies unique features in circulating CD8+ T cells that can predict immunotherapy response in melanoma patients Journal For Immunotherapy of Cancer. 8: A5.1-A5 |
| Chen J, Ye X, Pitmon E, et al. (2019) IL-17 inhibits CXCL9/10-mediated recruitment of CD8 cytotoxic T cells and regulatory T cells to colorectal tumors. Journal For Immunotherapy of Cancer. 7: 324 |
| Konstorum A, Vella AT, Adler AJ, et al. (2019) A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors. Scientific Reports. 9: 10862 |